Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers
Evidence is sparse regarding the clinical performance of luminescent oxygen channeling immunoassays–based tumor marker assays in gynecological cancer. Analyzing serum samples of 336 patients with Dimension™Vista1500, we investigated the diagnostic power of carbohydrate antigen 15-3, carbohydrate ant...
Saved in:
Main Authors: | Ramona C Dolscheid-Pommerich, Mignon Keyver-Paik, Thomas Hecking, Walther Kuhn, Gunther Hartmann, Birgit Stoffel-Wagner, Stefan Holdenrieder |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-10-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317730246 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Tumor Marker CA-125 in the Detection of Spontaneous Abortion
by: Mahdi, Batool Mutar
Published: (2012) -
Specific antitumor activity of anti-CA125 CAR-T lymphocytes against CA125-positive and CA125-negative cells
by: T. M. Kulinich, et al.
Published: (2024-07-01) -
RELATION BETWEEN REGULATORY T CELLS, CA-125 LEVEL AND TUMOR MASS IN OVARIAN CANCER PATIENTS
by: E. R. Chernykh, et al.
Published: (2014-07-01) -
Ultrafast and Ultrasensitive Simultaneous Molecular Recognition and Quantification of CA12-5, CA72-4, HER1, and AFP in Biological Samples
by: Ruxandra-Maria Ilie-Mihai, et al.
Published: (2025-06-01) -
Determination of Serum CA125 and evaluate its efficiency as screening tool For Early Detection of Ovarian Tumors
by: Baghdad Science Journal
Published: (2015-03-01)